This report covers the novel drug-coated balloon and drug-eluting stent technologies that are expected to trigger a paradigm shift in treatment of advanced peripheral artery disease-particularly lower extremity occlusions-driving the development of a new multi-billion dollar market. Also covered in the report are revascularization-enabling peripheral atherectomy systems and dedicated refractory CTO crossing devices that are projected to see above-average growth through 2019.
Aachen Resonance
Abbott Vascular (Abbott Laboratories)
Avinger Medical Technologies
Bard Peripheral (C.R. Bard)
Bayer HealthCare (Bayer AG)
Biosensors International
Biotronik
Boston Scientific
Cardionovum
Cardiovascular Systems
Cook Medical
Cordis (Johnson & Johnson)
Covidien
Eurocor (Opto Circuits)
iVascular
Medtronic
Medtronic plc
Spectranetics
Trusted By The Companies Pioneering What’s Next
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy